Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Jul;42(1):1–20. doi: 10.1038/bjc.1980.197

Malignant lymphomas as tumours of the immune system.

C W Berard, J Cossman, E S Jaffe
PMCID: PMC2010473  PMID: 7000112

Abstract

Malignant lymphomas have traditionally been classified on solely morphological grounds. With new immunological and cytochemical techniques, it has been possible to characterize normal cells of the T-lymphocyte, B-lymphocyte, and monocyte-macrophage system. Application of these methodologies to malignant lymphomas has established their nature as neoplasms of the immune system. Within the B-lymphocyte system it is possible to identify subpopulations responsible for Burkitt's tumour, follicular (nodular) lymphomas, lymphocytic lymphomas of intermediate differentiation and well differentiated lymphocytic lymphomas. The T-lymphocyte system includes lymphoblastic lymphomas, mycosis fungoides, and Sezary's syndrome. Large-cell lymphomas are diverse, but the majority are tumours of transformed lymphocytes, usually of the B-lymphocyte system. The precise nature of the neoplastic cells of Hodgkin's disease (i.e., Reed-Sternberg cells and their mononuclear counterparts) has not yet been established. Despite previous suggestions of a B-lymphocyte or T-lymphocyte origin, recent studies with in vitro cultivation have strongly suggested derivation from the monocyte-macrophage system.

Full text

PDF
4

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aisenberg A. C., Bloch K. J., Long J. C. Cell-surface immunoglobulins in chronic lymphocytic leukemia and allied disorders. Am J Med. 1973 Aug;55(2):184–191. doi: 10.1016/0002-9343(73)90167-8. [DOI] [PubMed] [Google Scholar]
  2. Aisenberg A. C., Long J. C. Lymphocyte surface characteristics in malignant lymphoma. Am J Med. 1975 Mar;58(3):300–306. doi: 10.1016/0002-9343(75)90595-1. [DOI] [PubMed] [Google Scholar]
  3. Aisenberg A. C. Malignant lymphoma. 1. N Engl J Med. 1973 Apr 26;288(17):883–890. doi: 10.1056/NEJM197304262881705. [DOI] [PubMed] [Google Scholar]
  4. Aisenberg A. C., Wilkes B. Lymphosarcoma cell leukemia: the contribution of cell surface study to diagnosis. Blood. 1976 Nov;48(5):707–715. [PubMed] [Google Scholar]
  5. Amlot P. L., Slaney J. M., Williams B. D. Circulating immune complexes and symptoms in Hodgkin's disease. Lancet. 1976 Feb 28;1(7957):449–451. doi: 10.1016/s0140-6736(76)91475-6. [DOI] [PubMed] [Google Scholar]
  6. Banks P. M., Arseneau J. C., Gralnick H. R., Canellos G. P., DeVita V. T., Jr, Berard C. W. American Burkitt's lymphoma: a clinicopathologic study of 30 cases. II. Pathologic correlations. Am J Med. 1975 Mar;58(3):322–329. doi: 10.1016/0002-9343(75)90598-7. [DOI] [PubMed] [Google Scholar]
  7. Biniaminov M., Ramot B. Letter: Possible T-lymphocyte origin of Reed-Sternberg cells. Lancet. 1974 Mar 2;1(7853):368–368. doi: 10.1016/s0140-6736(74)93138-9. [DOI] [PubMed] [Google Scholar]
  8. Bloomfield C. D., Kersey J. H., Brunning R. D., Gajl-Peczalska K. J. Prognostic significance of lymphocyte surface markers in adult non-Hodgkin's malignant lymphoma. Lancet. 1976 Dec 18;2(7999):1330–1333. doi: 10.1016/s0140-6736(76)91976-0. [DOI] [PubMed] [Google Scholar]
  9. Bloomfield C. D., Kersey J. H., Brunning R. D., Gajl-Peczalska K. J. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma. Cancer Treat Rep. 1977 Sep;61(6):963–970. [PubMed] [Google Scholar]
  10. Boecker W. R., Hossfeld D. K., Gallmeier W. M., Schmidt C. G. Clonal growth of Hodgkin cells. Nature. 1975 Nov 20;258(5532):235–236. doi: 10.1038/258235a0. [DOI] [PubMed] [Google Scholar]
  11. Bollum F. J. Terminal deoxynucleotidyl transferase as a hematopoietic cell marker. Blood. 1979 Dec;54(6):1203–1215. [PubMed] [Google Scholar]
  12. Braganza C. M., Stathopoulos G., Davies A. J., Elliott E. V., Kerbel R. S., Papamichail M., Holborow E. J. Lymphocyte: erythrocyte (L.E.) rosettes as indicators of the heterogeneity of lymphocytes in a variety of mammalian species. Cell. 1975 Feb;4(2):103–106. doi: 10.1016/0092-8674(75)90115-4. [DOI] [PubMed] [Google Scholar]
  13. Braylan R. C., Fowlkes B. J., Jaffe E. S., Sanders S. K., Berard C. W., Herman C. J. Cell volumes and DNA distributions of normal and neoplastic human lymphoid cells. Cancer. 1978 Jan;41(1):201–209. doi: 10.1002/1097-0142(197801)41:1<201::aid-cncr2820410129>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  14. Braylan R. C., Jaffe E. S., Berard C. W. Letter: Surface characteristics of Hodgkin's lymphoma cells. Lancet. 1974 Nov 30;2(7892):1328–1329. doi: 10.1016/s0140-6736(74)90198-6. [DOI] [PubMed] [Google Scholar]
  15. Braylan R. C., Jaffe E. S., Burbach J. W., Frank M. M., Johnson R. E., Berard C. W. Similarities of surface characteristics of neoplastic well-differentiated lymphocytes from solid tissues and from peripheral blood. Cancer Res. 1976 May;36(5):1619–1625. [PubMed] [Google Scholar]
  16. Braylan R. C., Long J. C., Jaffe E. S., Greco F. A., Orr S. L., Berard C. W. Malignant lymphoma obscured by concomitant extensive epithelioid granulomas: report of three cases with similar clinicopathologic features. Cancer. 1977 Mar;39(3):1146–1155. doi: 10.1002/1097-0142(197703)39:3<1146::aid-cncr2820390320>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  17. Brouet J. C., Flandrin G., Seligmann M. Indications of the thymus-derived nature of the proliferating cells in six patients with Sézary's syndrome. N Engl J Med. 1973 Aug 16;289(7):341–344. doi: 10.1056/NEJM197308162890703. [DOI] [PubMed] [Google Scholar]
  18. Brouet J. C., Preud'Homme J. L., Flandrin G., Chelloul N., Seligmann M. Membrane markers in "histiocytic" lymphomas (reticulum cell sarcomas). J Natl Cancer Inst. 1976 Mar;56(3):631–633. doi: 10.1093/jnci/56.3.631. [DOI] [PubMed] [Google Scholar]
  19. Brouet J. C., Sasportes M., Flandrin G., Preud'Homme J. L., Seligmann M. Chronic lymphocytic leukaemia of T-cell origin. Immunological and clinical evaluation in eleven patients. Lancet. 1975 Nov 8;2(7941):890–893. doi: 10.1016/s0140-6736(75)92127-3. [DOI] [PubMed] [Google Scholar]
  20. Casazza A. R., Duvall C. P., Carbone P. P. Summary of infectious complications occurring in patients with Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1290–1296. [PubMed] [Google Scholar]
  21. Catovsky D., Galetto J., Okos A., Miliani E., Galton D. A. Cytochemical profile of B and T leukaemic lymphocytes with special reference to acute lymphoblastic leukaemia. J Clin Pathol. 1974 Oct;27(10):767–771. doi: 10.1136/jcp.27.10.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Chabner B. A., Johnson R. E., DeVita V. T., Canellos G. P., Hubbard S. P., Johnson S. K., Young R. C. Sequential staging in non-Hodgkin's lymphoma. Cancer Treat Rep. 1977 Sep;61(6):993–997. [PubMed] [Google Scholar]
  23. Coccia P. F., Kersey J. H., Gajil-Peczalska K. J., Krivit W., Nesbit M. E. Prognostic significance of surface marker analysis in childhood non-Hodgkin's lymphoproliferative malifnancies. Am J Hematol. 1976;1(4):405–417. doi: 10.1002/ajh.2830010406. [DOI] [PubMed] [Google Scholar]
  24. Craddock C. G., Longmire R., McMillan R. Lymphocytes and the immune response. 2. N Engl J Med. 1971 Aug 12;285(7):378–384. doi: 10.1056/NEJM197108122850705. [DOI] [PubMed] [Google Scholar]
  25. Cullen M. H., Lister T. A., Brearley R. I., Shand W. S., Stansfeld A. G. Histological transformation of non-Hodgkin's lymphoma: a prospective study. Cancer. 1979 Aug;44(2):645–651. doi: 10.1002/1097-0142(197908)44:2<645::aid-cncr2820440234>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  26. DORFMAN R. F. Enzyme histochemistry of the cells in Hodgkin's disease and allied disorders. Nature. 1961 Jun 3;190:925–926. doi: 10.1038/190925a0. [DOI] [PubMed] [Google Scholar]
  27. DeVita V. T., Jr Lymphocyte reactivity in Hodgkin's disease: a lymphocyte civil war. N Engl J Med. 1973 Oct 11;289(15):801–802. doi: 10.1056/NEJM197310112891510. [DOI] [PubMed] [Google Scholar]
  28. Donlon J. A., Jaffe E. S., Braylan R. C. Terminal deoxynucleotidyl transferase activity in malignant lymphomas. N Engl J Med. 1977 Sep 1;297(9):461–464. doi: 10.1056/NEJM197709012970901. [DOI] [PubMed] [Google Scholar]
  29. Fisher R. I., Jaffe E. S., Braylan R. C., Andersen J. C., Tan H. K. Immunoblastic lymphadenopathy. Evolution into a malignant lymphoma with plasmacytoid features. Am J Med. 1976 Oct;61(4):553–559. doi: 10.1016/0002-9343(76)90337-5. [DOI] [PubMed] [Google Scholar]
  30. Flandrin G., Brouet J. C. The Sezary cell: cytologic, cytochemical, and immunologic studies. Mayo Clin Proc. 1974 Aug;49(8):575–583. [PubMed] [Google Scholar]
  31. Fu S. M., Chiorazzi N., Kunkel H. G., Halper J. P., Harris S. R. Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes. J Exp Med. 1978 Dec 1;148(6):1570–1578. doi: 10.1084/jem.148.6.1570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Fu S. M., Winchester R. J., Feizi T., Walzer P. D., Kunkel H. G. Idiotypic specificity of surface immunoglobulin and the maturation of leukemic bone-marrow-derived lymphocytes. Proc Natl Acad Sci U S A. 1974 Nov;71(11):4487–4490. doi: 10.1073/pnas.71.11.4487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Fuks Z., Strober S., Kaplan H. S. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test. N Engl J Med. 1976 Dec 2;295(23):1273–1278. doi: 10.1056/NEJM197612022952301. [DOI] [PubMed] [Google Scholar]
  34. Garvin A. J., Spicer S. S., Parmley R. T., Munster A. M. Immunohistochemical demonstration of IgG in Reed-Sternberg and other cells in Hodgkin's disease. J Exp Med. 1974 May 1;139(5):1077–1083. doi: 10.1084/jem.139.5.1077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Gatien J. G., Schneeberger E. E., Merler E. Analysis of human thymocyte subpopulations using discontinuous gradients of albumin: precursor lymphocytes in human thymus. Eur J Immunol. 1975 May;5(5):312–317. doi: 10.1002/eji.1830050505. [DOI] [PubMed] [Google Scholar]
  36. Glick A. D., Leech J. H., Flexner J. M., Collins R. D. Ultrastructural study of Reed-Sternberg cells. Comparison with transformed lymphocytes and histiocytes. Am J Pathol. 1976 Oct;85(1):195–208. [PMC free article] [PubMed] [Google Scholar]
  37. Habeshaw J. A., Stuart A. E. Cell receptor studies on seven cases of diffuse histiocytic malignant lymphoma (reticulum cell sarcoma). J Clin Pathol. 1975 Apr;28(4):289–297. doi: 10.1136/jcp.28.4.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Jaffe E. S., Berard C. W. Lymphoblastic lymphoma, a term rekindled with new precision. Ann Intern Med. 1978 Sep;89(3):415–417. doi: 10.7326/0003-4819-89-3-415. [DOI] [PubMed] [Google Scholar]
  39. Jaffe E. S., Braylan R. C., Frank M. M., Green I., Berard C. W. Heterogeneity of immunologic markers and surface morphology in childhood lymphoblastic lymphoma. Blood. 1976 Aug;48(2):213–222. [PubMed] [Google Scholar]
  40. Jaffe E. S., Shevach E. M., Frank M. M., Berard C. W., Green I. Nodular lymphoma--evidence for origin from follicular B lymphocytes. N Engl J Med. 1974 Apr 11;290(15):813–819. doi: 10.1056/NEJM197404112901501. [DOI] [PubMed] [Google Scholar]
  41. Jaffe E. S., Shevach E. M., Sussman E. H., Frank M., Green I., Berard C. W. Membrane receptor sites for the identification of lymphoreticular cells in benign and malignant conditions. Br J Cancer Suppl. 1975 Mar;2:107–120. [PMC free article] [PubMed] [Google Scholar]
  42. Jones S. E., Fuks Z., Bull M., Kadin M. E., Dorfman R. F., Kaplan H. S., Rosenberg S. A., Kim H. Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer. 1973 Apr;31(4):806–823. doi: 10.1002/1097-0142(197304)31:4<806::aid-cncr2820310408>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  43. KELLY W. D., LAMB D. L., VARCO R. L., GOOD R. A. An investigation of Hodgkin's disease with respect to the problem of homotransplantation. Ann N Y Acad Sci. 1960 May 31;87:187–202. doi: 10.1111/j.1749-6632.1960.tb23192.x. [DOI] [PubMed] [Google Scholar]
  44. Kadin M. E., Stites D. P., Levy R., Warnke R. Exogenous immunoglobulin and the macrophage origin of Reed-Sternberg cells in Hodgkin's disease. N Engl J Med. 1978 Nov 30;299(22):1208–1214. doi: 10.1056/NEJM197811302992203. [DOI] [PubMed] [Google Scholar]
  45. Kay M. M., Kadin M. Letter: Surface characteristics of Hodgkin's cells. Lancet. 1975 Mar 29;1(7909):748–749. doi: 10.1016/s0140-6736(75)91661-x. [DOI] [PubMed] [Google Scholar]
  46. Kersey J. H., Gajl-Peczalska K. J., Coccia P. F., Nesbit M. E. The nature of childhood leukemia and lymphoma. Am J Pathol. 1978 Feb;90(2):487–495. [PMC free article] [PubMed] [Google Scholar]
  47. Kersey J. H., Sabad A., Gajl-Peczalska K., Hallgren H. M., Yunis E. J., Nesbit M. E. Acute lymphoblastic leukemic cells with T (thymus-derived) lymphocyte markers. Science. 1973 Dec 28;182(4119):1355–1356. doi: 10.1126/science.182.4119.1355. [DOI] [PubMed] [Google Scholar]
  48. Lawrence E. C., Broder S., Jaffe E. S., Braylan R. C., Dobbins W. O., Young R. C., Waldmann T. A. Evolution of a lymphoma with helper T cell characteristics in Sézary syndrome. Blood. 1978 Sep;52(3):481–492. [PubMed] [Google Scholar]
  49. Levine G. D., Dorfman R. F. Nodular lymphoma: an ultrastructural study of its relationship to germinal centers and a correlation of light and electron microscopic findings. Cancer. 1975 Jan;35(1):148–164. doi: 10.1002/1097-0142(197501)35:1<148::aid-cncr2820350121>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  50. Logue G. L., Cohen H. J. Human lymphocyte complement receptors. Quantitative requirements for C3 of normal and chronic lymphocyte leukemia lymphocytes. J Clin Invest. 1977 Nov;60(5):1159–1164. doi: 10.1172/JCI108868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Lohrmann Hans-Peter, Novikovs L. Rosette formation between human T-lymphocytes and unsensitized rhesus monkey erythrocytes. Clin Immunol Immunopathol. 1974 Sep;3(1):99–111. doi: 10.1016/0090-1229(74)90027-0. [DOI] [PubMed] [Google Scholar]
  52. Long J. C., Aisenberg A. C. Richter's syndrome. A terminal complication of chronic lymphocytic leukemia with distinct clinicopathologic features. Am J Clin Pathol. 1975 Jun;63(6):786–795. doi: 10.1093/ajcp/63.6.786. [DOI] [PubMed] [Google Scholar]
  53. Long J. C., Hall C. L., Brown C. A., Stamatos C., Weitzman S. A., Carey K. Binding of soluble immune complexes in serum of patients with Hodgkin's disease to tissue cultures derived from the tumor. N Engl J Med. 1977 Aug 11;297(6):295–299. doi: 10.1056/NEJM197708112970602. [DOI] [PubMed] [Google Scholar]
  54. Long J. C., McCaffrey R. P., Aisenberg A. C., Marks S. M., Kung P. C. Terminal deoxynucleotidyl transferase positive lymphoblastic lymphoma: a study of 15 cases. Cancer. 1979 Dec;44(6):2127–2139. doi: 10.1002/1097-0142(197912)44:6<2127::aid-cncr2820440625>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  55. Long J. C. The immunopathology of Hodgkin's disease. Clin Haematol. 1979 Oct;8(3):531–566. doi: 10.1016/s0308-2261(79)80003-x. [DOI] [PubMed] [Google Scholar]
  56. Long J. C., Zamecnik P. C., Aisenberg A. C., Atkins L. Tissue culture studies in Hodgkin's disease: Morphologic, cytogenetic, cell surface, and enzymatic properties of cultures derived from splenic tumors. J Exp Med. 1977 Jun 1;145(6):1484–1500. doi: 10.1084/jem.145.6.1484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Lukes R. J., Butler J. J. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1063–1083. [PubMed] [Google Scholar]
  58. Lukes R. J., Collins R. D. Immunologic characterization of human malignant lymphomas. Cancer. 1974 Oct;34(4 Suppl):suppl–suppl:1503. doi: 10.1002/1097-0142(197410)34:8+<1488::aid-cncr2820340822>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  59. Lukes R. J., Parker J. W., Taylor C. R., Tindle B. H., Cramer A. D., Lincoln T. L. Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases. Semin Hematol. 1978 Oct;15(4):322–351. [PubMed] [Google Scholar]
  60. Lukes R. J., Taylor C. R., Parker J. W., Lincoln T. L., Pattengale P. K., Tindle B. H. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias. Am J Pathol. 1978 Feb;90(2):461–486. [PMC free article] [PubMed] [Google Scholar]
  61. Lutzner M., Edelson R., Schein P., Green I., Kirkpatrick C., Ahmed A. Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders. Ann Intern Med. 1975 Oct;83(4):534–552. doi: 10.7326/0003-4819-83-4-534. [DOI] [PubMed] [Google Scholar]
  62. Mann R. B., Berard C. W. Burkitt's tumour: Lessons from mice, monkeys, and man. Lancet. 1977 Jul 9;2(8028):84–84. doi: 10.1016/s0140-6736(77)90080-0. [DOI] [PubMed] [Google Scholar]
  63. Mann R. B., Jaffe E. S., Braylan R. C., Nanba K., Frank M. M., Ziegler J. L., Berard C. W. Non-endemic Burkitts's lymphoma. A B-cell tumor related to germinal centers. N Engl J Med. 1976 Sep 23;295(13):685–691. doi: 10.1056/NEJM197609232951301. [DOI] [PubMed] [Google Scholar]
  64. Morris M. W., Davey F. R. Immunologic and cytochemical properties of histiocytic and mixed histiocytic-lymphocytic lymphomas. Am J Clin Pathol. 1975 Mar;63(3):403–414. doi: 10.1093/ajcp/63.3.403. [DOI] [PubMed] [Google Scholar]
  65. Nanba K., Jaffe E. S., Braylan R. C., Soban E. J., Berard C. W. Alkaline phosphatase-positive malignant lymphoma. A subtype of B-cell lymphomas. Am J Clin Pathol. 1977 Nov;68(5):535–542. doi: 10.1093/ajcp/68.5.535. [DOI] [PubMed] [Google Scholar]
  66. Nathwani B. N., Kim H., Rappaport H. Malignant lymphoma, lymphoblastic. Cancer. 1976 Aug;38(2):964–983. doi: 10.1002/1097-0142(197608)38:2<964::aid-cncr2820380248>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  67. O'Connell C. J. Letter: Detection of lymphocyte resettes in tissues. N Engl J Med. 1973 Dec 13;289(24):1312–1313. doi: 10.1056/NEJM197312132892417. [DOI] [PubMed] [Google Scholar]
  68. Order S. E., Hellman S. Pathogenesis of Hodgkin's disease. Lancet. 1972 Mar 11;1(7750):571–573. doi: 10.1016/s0140-6736(72)90360-1. [DOI] [PubMed] [Google Scholar]
  69. Pangalis G. A., Nathwani B. N., Rappaport H. Malignant lymphoma, well differentiated lymphocytic: its relationship with chronic lymphocytic leukemia and macroglobulinemia of Waldenström. Cancer. 1977 Mar;39(3):999–1010. doi: 10.1002/1097-0142(197703)39:3<999::aid-cncr2820390302>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  70. Payne S. V., Jones D. B., Haegert D. G., Smith J. L., Wright D. H. T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens. Clin Exp Immunol. 1976 May;24(2):280–286. [PMC free article] [PubMed] [Google Scholar]
  71. Peckham M. J., Cooper E. H. Proliferation characteristics of the various classes of cells in Hodgkin's disease. Cancer. 1969 Jul;24(1):135–146. doi: 10.1002/1097-0142(196907)24:1<135::aid-cncr2820240118>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  72. Peter C. R., MacKenzie M. R., Glassy F. J. T or B cell origin of some non-Hodgkin's lymphomas. Lancet. 1974 Sep 21;2(7882):686–689. doi: 10.1016/s0140-6736(74)93263-2. [DOI] [PubMed] [Google Scholar]
  73. Pinkus G. S., Said J. W., Hargreaves H. Malignant lymphoma, T-cell type. A distinct morphologic variant with large multilobated nuclei, with a report of four cases. Am J Clin Pathol. 1979 Oct;72(4):540–550. doi: 10.1093/ajcp/72.4.540. [DOI] [PubMed] [Google Scholar]
  74. Poppema S., Elema J. D., Halie M. R. The significance of intracytoplasmic proteins in Reed-Sternberg cells. Cancer. 1978 Oct;42(4):1793–1803. doi: 10.1002/1097-0142(197810)42:4<1793::aid-cncr2820420418>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  75. Potvin C., Tarpley J. L., Chretien B. Thymus-derived lymphocytes in patients with solid malignancies. Clin Immunol Immunopathol. 1975 Mar;3(4):476–481. doi: 10.1016/0090-1229(75)90072-0. [DOI] [PubMed] [Google Scholar]
  76. Preud'homme J. L., Seligmann M. Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases. Blood. 1972 Dec;40(6):777–794. [PubMed] [Google Scholar]
  77. Qazi R., Aisenberg A. C., Long J. C. The natural history of nodular lymphoma. Cancer. 1976 Apr;37(4):1923–1927. doi: 10.1002/1097-0142(197604)37:4<1923::aid-cncr2820370443>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  78. Risdall R., Hoppe R. T., Warnke R. Non-Hodgkin's lymphoma: a study of the evolution of the disease based upon 92 autopsied cases. Cancer. 1979 Aug;44(2):529–542. doi: 10.1002/1097-0142(197908)44:2<529::aid-cncr2820440222>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  79. Roberts A. N., Smith K. L., Dowell B. L., Hubbard A. K. Cultural, morphological, cell membrane, enzymatic, and neoplastic properties of cell lines derived from a Hodgkin's disease lymph node. Cancer Res. 1978 Sep;38(9):3033–3043. [PubMed] [Google Scholar]
  80. Robinowitz B. N., Noguchi S., Roenigk H. H., Jr Tumor cell characterization in mycosis fungoides. Cancer. 1976 Apr;37(4):1747–1753. doi: 10.1002/1097-0142(197604)37:4<1747::aid-cncr2820370420>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  81. Sandilands G. P., Gray K., Cooney A., Browning J. D. Formation of auto-rosettes by peripheral blood lymphocytes. Clin Exp Immunol. 1975 Dec;22(3):493–501. [PMC free article] [PubMed] [Google Scholar]
  82. Schein P. S., DeVita V. T., Jr, Hubbard S., Chabner B. A., Canellos G. P., Berard C., Young R. C. Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. Ann Intern Med. 1976 Oct;85(4):417–422. doi: 10.7326/0003-4819-85-4-417. [DOI] [PubMed] [Google Scholar]
  83. Schmitt D., Alario A., Perrot H., Thivolet J. Origin of Reed-Sternberg cell. Lancet. 1977 Jul 16;2(8029):137–137. doi: 10.1016/s0140-6736(77)90144-1. [DOI] [PubMed] [Google Scholar]
  84. Sen L., Borella L. Clinical importance of lymphoblasts with T markers in childhood acute leukemia. N Engl J Med. 1975 Apr 17;292(16):828–832. doi: 10.1056/NEJM197504172921604. [DOI] [PubMed] [Google Scholar]
  85. Stein H., Müller-Hermelink H. K. Simultaneous presence of receptors for complement and sheep red blood cells on human fetal thymocytes. Br J Haematol. 1977 Jun;36(2):225–230. doi: 10.1111/j.1365-2141.1977.tb00643.x. [DOI] [PubMed] [Google Scholar]
  86. Stein H., Petersen N., Gaedicke G., Lennert K., Landbeck G. Lymphoblastic lymphoma of convoluted or acid phosphatase type-a tumor of T precursor cells. Int J Cancer. 1976 Mar 15;17(3):292–295. doi: 10.1002/ijc.2910170303. [DOI] [PubMed] [Google Scholar]
  87. Suchi T., Tajima K., Nanba K., Wakasa H., Mikata A., Kikuchi M., Mori S., Watanabe S., Mohri N., Shamoto M. Some problems on the histopathological diagnosis of non-Hodgkin's malignant lymphoma -- a proposal of a new type. Acta Pathol Jpn. 1979 Sep;29(5):755–776. doi: 10.1111/j.1440-1827.1979.tb00942.x. [DOI] [PubMed] [Google Scholar]
  88. Taylor C. R. An immunohistological study of follicular lymphoma, reticulum cell sarcoma and Hodgkin's disease. Eur J Cancer. 1976 Jan;12(1):61–75. doi: 10.1016/0014-2964(76)90125-0. [DOI] [PubMed] [Google Scholar]
  89. Taylor C. R. The nature of Reed-Sternberg cells and other malignant "reticulum" cells. Lancet. 1974 Oct 5;2(7884):802–807. doi: 10.1016/s0140-6736(74)91071-x. [DOI] [PubMed] [Google Scholar]
  90. Tonder O., Morse P. A., Jr, Humphrey L. J. Similarities of Fc receptors in human malignant tissue and normal lymphoid tissue. J Immunol. 1974 Oct;113(4):1162–1169. [PubMed] [Google Scholar]
  91. Tsukimoto I., Wong K. Y., Lampkin B. C. Surface markers and prognostic factors in acute lymphoblastic leukemia. N Engl J Med. 1976 Jan 29;294(5):245–248. doi: 10.1056/NEJM197601292940503. [DOI] [PubMed] [Google Scholar]
  92. Uchiyama T., Yodoi J., Sagawa K., Takatsuki K., Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977 Sep;50(3):481–492. [PubMed] [Google Scholar]
  93. Waldron J. A., Leech J. H., Glick A. D., Flexner J. M., Collins R. D. Malignant lymphoma of peripheral T-lymphocyte origin: immunologic, pathologic, and clinical features in six patients. Cancer. 1977 Oct;40(4):1604–1617. doi: 10.1002/1097-0142(197710)40:4<1604::aid-cncr2820400433>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  94. Weiner M. S., Bianco C., Nussenzweig V. Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes. Blood. 1973 Dec;42(6):939–946. [PubMed] [Google Scholar]
  95. Weinstein H. J., Vance Z. B., Jaffe N., Buell D., Cassady J. R., Nathan D. G. Improved prognosis for patients with mediastinal lymphoblastic lymphoma. Blood. 1979 Apr;53(4):687–694. [PubMed] [Google Scholar]
  96. Woda B. A., Knowles D. M., 2nd Nodular lymphocytic lymphoma eventuating into diffuse histiocytic lymphoma: immunoperoxidase demonstration of monoclonality. Cancer. 1979 Jan;43(1):303–307. doi: 10.1002/1097-0142(197901)43:1<303::aid-cncr2820430144>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  97. Wybran J., Carr M. C., Fudenberg H. H. The human rosette-forming cell as a marker of a population of thymus-derived cells. J Clin Invest. 1972 Oct;51(10):2537–2543. doi: 10.1172/JCI107069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Young R. C., Corder M. P., Haynes H. A., DeVita V. T. Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients. Am J Med. 1972 Jan;52(1):63–72. doi: 10.1016/0002-9343(72)90008-3. [DOI] [PubMed] [Google Scholar]
  99. Ziegler J. L. Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience. N Engl J Med. 1977 Jul 14;297(2):75–80. doi: 10.1056/NEJM197707142970202. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES